Citalopram hydrobromide and Electrocardiogram st segment elevation - a phase IV clinical study of FDA data
Summary:
Electrocardiogram st segment elevation is reported as a side effect among people who take Citalopram hydrobromide (citalopram hydrobromide), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Fluorouracil, and have Rectal cancer.
The phase IV clinical study analyzes which people have Electrocardiogram st segment elevation when taking Citalopram hydrobromide. It is created by eHealthMe based on reports of 32,819 people who have side effects when taking Citalopram hydrobromide from the FDA, and is updated regularly.
What is Citalopram hydrobromide?
Citalopram hydrobromide has active ingredients of citalopram hydrobromide. It is often used in depression. eHealthMe is studying from 36,878 Citalopram hydrobromide users. Check the latest studies of Citalopram hydrobromide.
What is Electrocardiogram st segment elevation?
Electrocardiogram st segment elevation is found to be associated with 397 drugs and 812 conditions by eHealthMe. Check the latest studies of Electrocardiogram st segment elevation.
32,819 people reported to have side effects when taking Citalopram hydrobromide.
Among them, 15 people (0.05%) have Electrocardiogram st segment elevation.
Among these 15 people:
How long have people been on Citalopram hydrobromide when they have Electrocardiogram st segment elevation? *
- < 1 month: 0.0 %
- 1 - 6 months: 100 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Electrocardiogram st segment elevation when taking Citalopram hydrobromide? *
- female: 28.57 %
- male: 71.43 %
What is the age of people who have Electrocardiogram st segment elevation when taking Citalopram hydrobromide? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 7.69 %
- 30-39: 0.0 %
- 40-49: 7.69 %
- 50-59: 0.0 %
- 60+: 84.62 %
What are other drugs people take besides Citalopram hydrobromide? *
- Fluorouracil: 9 people, 60.00%
- Simvastatin: 5 people, 33.33%
- Acetylcysteine: 2 people, 13.33%
- Fluconazole: 2 people, 13.33%
- Omeprazole: 2 people, 13.33%
- Zopiclone: 1 person, 6.67%
- Didanosine: 1 person, 6.67%
- Isoniazid: 1 person, 6.67%
- Ethambutol Hydrochloride: 1 person, 6.67%
- Erlotinib Hydrochloride: 1 person, 6.67%
What are other side effects people have besides Electrocardiogram st segment elevation? *
- Sinus Bradycardia (an unusually slow heartbeat due to heart disease): 9 people, 60.00%
- Haemoglobin Decreased: 7 people, 46.67%
- Fatigue (feeling of tiredness): 7 people, 46.67%
- Crepitations (noises are produced by the rubbing of parts one against the other): 5 people, 33.33%
- Dizziness: 4 people, 26.67%
- Cardiotoxicity (damage to the heart muscle): 3 people, 20.00%
- C-Reactive Protein Increased: 3 people, 20.00%
- Presyncope: 2 people, 13.33%
- Disease Progression: 2 people, 13.33%
- Diarrhea: 2 people, 13.33%
What are the existing conditions these people have? *
- Rectal Cancer (cancer of rectum): 7 people, 46.67%
- Lung Cancer - Non-Small Cell (lung cancer): 2 people, 13.33%
- Back Pain: 2 people, 13.33%
- Suicide Attempt: 1 person, 6.67%
- Sinus Bradycardia (an unusually slow heartbeat due to heart disease): 1 person, 6.67%
- Oral Candidiasis (fungal infection of mouth): 1 person, 6.67%
- Mycobacterium Avium Complex Infection: 1 person, 6.67%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 6.67%
- Hiv Infection: 1 person, 6.67%
- Dyslipidaemia (abnormal amount of lipids): 1 person, 6.67%
* Approximation only. Some reports may have incomplete information.
Do you take Citalopram hydrobromide and have Electrocardiogram st segment elevation?
- Check whether Electrocardiogram st segment elevation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Citalopram hydrobromide:
- Citalopram hydrobromide (36,878 reports)
Electrocardiogram st segment elevation treatments and more:
- Electrocardiogram st segment elevation (4,750 reports)
How severe was Electrocardiogram st segment elevation and when was it recovered:
Expand to all the drugs that have ingredients of citalopram hydrobromide:
- Electrocardiogram st segment elevation and drugs with ingredients of citalopram hydrobromide (71 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Citalopram hydrobromide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Electrocardiogram st segment elevation:
- Electrocardiogram st segment elevation (397 drugs)
Browse all the conditions that are associated with Electrocardiogram st segment elevation:
- Electrocardiogram st segment elevation (812 conditions)
Related publications that referenced our studies
- Hosseini, S. H., & Ahmadi, A., "Peripheral edema occurring during treatment with risperidone combined with citalopram", Case reports in medicine, 2012 Jan .
- Hosseini, S. H., & Ahmadi, A., "Peripheral edema occurring during treatment with risperidone combined with citalopram", Case reports in medicine, 2012 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on citalopram hydrobromide (the active ingredients of Citalopram hydrobromide) and Citalopram hydrobromide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Tapentadol Hydrochloride cause Depression Aggravated? - 7 seconds ago
- T-Cell Lymphoma and Nosebleed - 10 seconds ago
- Drug interactions of Amlodipine Besylate and Nourianz - 19 seconds ago
- Drug interactions of Myrbetriq and Fml - 26 seconds ago
- Drug interactions of Fluconazole and Saccharomyces Boulardii - 27 seconds ago
- Drug interactions of Strensiq and Claritin - 30 seconds ago
- Drug interactions of Stelara and Paxil - 33 seconds ago
- Drug interactions of Lipoic Acid and Cozaar - 37 seconds ago
- Drug interactions of Carboplatin and Venofer - 43 seconds ago
- Small Intestine Carcinoma and Abdominal Pain - 48 seconds ago